The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.
Hepatitis B virus (HBV) infection is a major risk for hepatocellular carcinoma (HCC), and it is a serious global health problem with two billion people exposed to it worldwide. HBx, an essential factor for viral replication and a putative oncoprotein encoded by the HBV genome, has been shown to prom...
Main Authors: | Tatsuo Kido, Jing-Hsiung James Ou, Yun-Fai Chris Lau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3146538?pdf=render |
Similar Items
-
Hepatitis B Virus HBx Protein Interactions with the Ubiquitin Proteasome System
by: Marissa M. Minor, et al.
Published: (2014-11-01) -
Apoptotic effect induced by hepatitis B virus X protein (HBx) in the CCL13-HBx (Chang-HBx) stable cell line
by: Ju-I Tsai, et al.
Published: (2009) -
Functional role of selective HBx-targeted proteasomic genes in cell growth and apoptosis
by: Hui Shan Cheng, et al.
Published: (2009) -
The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression
by: Tatsuo Kido, et al.
Published: (2019-03-01) -
Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12
by: Omar M. Khan, et al.
Published: (2021-04-01)